Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (1) Daniel, Peter Prof. Dr. (1) Ittermann, Bernd Dr. (1) Kammertöns, Thomas Dr. (4) Kettenmann, Helmut Prof. Dr. (2) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Millward, Jason Dr. (1) Niendorf, Thoralf Prof. Dr. (28) Paul, Friedemann Prof. Dr. med. (2) Pezzutto, Antonio Prof. Dr. (1) Qadri, Fatimunnisa Dr. (1) Schulz-Menger, Jeanette Prof. Dr. (5) Uckert, Wolfgang Prof. Dr. (1) Waiczies, Helmar Dr. (8) Waiczies, Sonia PD Dr. (7) Winter, Lukas Dr. (4) Wolf, Susanne Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (17) (-) Ku, Min-Chi Dr. (2) (-) Willimsky, Gerald Dr. (6) (-) Experimentelle Ultrahochfeld-MR (3) Genetik metabolischer und reproduktiver Störungen (1) Magnetic Resonance (3) (-) Molekulare Immunologie und Gentherapie (18) Psychoneuroimmunologie (2) Zelluläre Neurowissenschaften (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) (-) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (6) 2012 (8) (-) 2013 (15) 2014 (6) 2015 (10) 2016 (11) 2017 (12) 2018 (11) 2019 (8) 2020 (5) 2021 (10) 2022 (12) 2023 (10) 2024 (4) 21 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Ku, Min-Chi Dr.Willimsky, Gerald Dr.Experimentelle Ultrahochfeld-MRMolekulare Immunologie und Gentherapie 200220062013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. April 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler 03. Juni 2002 / J Exp Med Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction Z. Qin H.J. Kim J. Hemme T. Blankenstein 15. Mai 2002 / Canc Res Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors Z. Qin C. Harders X. Cao C. Huber T. Blankenstein B. Seliger 01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel 01. August 2002 / J Mol Med Naive CD8+ but not CD4+ T cells induce maturation of dendritic cells T. Schueler T. Blankenstein 22. April 2013 / PLoS ONE Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla L. Winter C. Özerdem W. Hoffmann D. Santoro A. Müller H. Waiczies R. Seemann A. Graessl P. Wust T. Niendorf 01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya 15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. April 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler
03. Juni 2002 / J Exp Med Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction Z. Qin H.J. Kim J. Hemme T. Blankenstein
15. Mai 2002 / Canc Res Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors Z. Qin C. Harders X. Cao C. Huber T. Blankenstein B. Seliger
01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
01. August 2002 / J Mol Med Naive CD8+ but not CD4+ T cells induce maturation of dendritic cells T. Schueler T. Blankenstein
22. April 2013 / PLoS ONE Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla L. Winter C. Özerdem W. Hoffmann D. Santoro A. Müller H. Waiczies R. Seemann A. Graessl P. Wust T. Niendorf
01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya
15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel